EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Fatal Case of Immune-Related Myocarditis and Myositis Due to Treatment with Immune Checkpoint and Tyrosine Kinase Inhibitors

João Queirós Coelho, Joana Simões, Tomás Fonseca, Sérgio Xavier Azevedo, António Araújo

Acta Médica Portuguesa · 2024

DOI: 10.20344/amp.21306 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Acta Médica Portuguesa, 2024. Verfasst von João Queirós Coelho und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Service. Hospital de Santo António. Unidade Local de Saúde de Santo António. Porto. Portugal. Hauptthemen laut MEDLINE: Myocarditis, Myositis, Immune Checkpoint Inhibitors, Protein Kinase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitor and tyrosine kinase inhibitor combinations have become the new standard of care in the first-line treatment of metastatic clear cell renal cell carcinoma. However, there is a growing concern regarding severe immune-related adverse events. A 78-year-old man with metastatic clear cell renal cell carcinoma, treated with pembrolizumab and axitinib, was admitted to the emergency department 30 days after initiating treatment due to rapidly progressive myositis. Myocarditis with severe ventricular dysfunction was identified. Muscular biopsy findings were compatible with inflammatory myopathy associated with immune checkpoint inhibitors. Initial treatment with high-dose corticosteroids showed an insufficient response. Therapeutic escalation on the third day with methylprednisolone, immunoglobulin, and abatacept resulted in clinical improvement. On the eleventh day, a sudden malignant arrhythmia occurred, followed by cardiac arrest. This represents one of the first case reports describing myocarditis and myositis during treatment with pembrolizumab-axitinib. While immune checkpoint inhibitor may play a major role, it is also possible that the tyrosine kinase inhibitor, while attempting to promote immune modulation, also increases severe toxicities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocarditisMyositisImmune Checkpoint InhibitorsProtein Kinase InhibitorsAntibodies, Monoclonal, HumanizedCarcinoma, Renal CellHumansMaleAgedFatal OutcomeAxitinibKidney NeoplasmsTyrosine Kinase Inhibitors

Stichwörter der Autor:innen

CarcinomaImmune Checkpoint Inhibitors/adverse effectsMyocarditis/chemically inducedMyositis/chemically inducedRenal Cell/drug therapyTyrosine Kinase Inhibitors/adverse effects

Substanzen

Immune Checkpoint InhibitorsProtein Kinase InhibitorsAntibodies, Monoclonal, HumanizedpembrolizumabAxitinibTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Medical Oncology Service. Hospital de Santo António. Unidade Local de Saúde de Santo António. Porto. Portugal.
  • Clinical Immunology Unit. Unidade Local de Saúde de Santo António. Porto. Portugal.
  • Medical Oncology Service. Hospital de Santo António. Unidade Local de Saúde de Santo António. Porto; Oncology Research Unit. Unit for Multidisciplinary Research in Biomedicine (UMIB). School of Medicine and Biomedical S…

Zitieren

APA

Queirós Coelho, J., Simões, J., Fonseca, T., Xavier Azevedo, S., & Araújo, A. (2024). Fatal Case of Immune-Related Myocarditis and Myositis Due to Treatment with Immune Checkpoint and Tyrosine Kinase Inhibitors. Acta Médica Portuguesa. https://doi.org/10.20344/amp.21306

Vancouver

Queirós Coelho J, Simões J, Fonseca T, Xavier Azevedo S, Araújo A. Fatal Case of Immune-Related Myocarditis and Myositis Due to Treatment with Immune Checkpoint and Tyrosine Kinase Inhibitors. Acta Médica Portuguesa. 2024. doi:10.20344/amp.21306

BibTeX
@article{QueirsCoelho2024,
  author = {Queirós Coelho, João and Simões, Joana and Fonseca, Tomás and Xavier Azevedo, Sérgio and Araújo, António},
  title = {Fatal Case of Immune-Related Myocarditis and Myositis Due to Treatment with Immune Checkpoint and Tyrosine Kinase Inhibitors},
  journal = {Acta Médica Portuguesa},
  year = {2024},
  doi = {10.20344/amp.21306}
}
Kostenlos starten →